Skip to main content

norelgestromin and ethinyl estradiol 35 ug/d / 150 ug/d Medicare Part D Coverage

Brand name: XULANE
Dosage form
PATCH
Route
TRANSDERMAL
89%
of Medicare Part D plans
cover norelgestromin and ethinyl estradiol
4,941 of 5,530 plans
2.9
Avg. formulary tier
$15.00
Median 30-day copay
$0.00–$30.00
Copay range

Formulary Tier Distribution

How Medicare Part D plans classify norelgestromin and ethinyl estradiol. Lower tiers = lower copays.

Tier 1 - Preferred Generic 3%
161 plans • avg $0.00/mo
Tier 2 - Generic 11%
560 plans • avg $1.21/mo
Tier 3 - Preferred Brand 81%
3,980 plans • avg $2.61/mo
Tier 4 - Non-Preferred Drug 5%
240 plans • avg $2.33/mo

Find the cheapest plan for norelgestromin and ethinyl estradiol

Enter your ZIP code to compare every plan in your area side-by-side.

Compare Plans for norelgestromin and ethinyl estradiol →

Get norelgestromin and ethinyl estradiol Delivered to Your Door

Compare prices and get discounts from trusted online pharmacies

DrugCovered may earn commissions from pharmacy purchases. Prices and availability vary. Always consult your doctor before starting or changing medications.

norelgestromin and ethinyl estradiol Medicare Coverage by State

Coverage rates and average costs vary significantly by state. Click a state to see the specific plans available there.

Frequently Asked Questions about norelgestromin and ethinyl estradiol

89% of Medicare Part D plans cover norelgestromin and ethinyl estradiol. It is most commonly placed on Tier 3. Coverage varies by plan and geographic area.

The median 30-day copay for norelgestromin and ethinyl estradiol on Medicare Part D is $15.00 at a preferred pharmacy. Costs range from $0.00 to $30.00 depending on the plan.

norelgestromin and ethinyl estradiol is placed on Tier 3 by most Medicare Part D plans. Lower tier numbers generally mean lower copays.

0% of plans require prior authorization for norelgestromin and ethinyl estradiol. Prior authorization means your doctor must confirm the drug is medically necessary before the plan will cover it.

Coverage statistics based on CMS formulary data for plan year 2026. Data updated regularly. Methodology →